0% found this document useful (0 votes)
38 views12 pages

Test Report: Mr. Kushal S 09-Jun-2024 / 08:43 AM 09-Jun-2024 / 08:33 AM

Uploaded by

dimpu2420
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
38 views12 pages

Test Report: Mr. Kushal S 09-Jun-2024 / 08:43 AM 09-Jun-2024 / 08:33 AM

Uploaded by

dimpu2420
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 12

TEST REPORT

Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM


Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:53 AM
Collected At : - Report : 09-Jun-2024 / 14:03 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Biochemistry
Tests Result Units Biological Reference Range Specimen

KIDNEY FUNCTION TEST


UREA 14.0 mg/dl <39 Serum
Method:UREASE

CREATININE 0.89 mg/dl 0.60-1.10 Serum


Method:Enzymatic

URIC ACID 7.1 mg/dl 3.7-9.2 Serum


Method:Uricase

CALCIUM 10.1 mg/dl 8.5-10.1 Serum


Method:ARSENAZO III method

PHOSPHORUS 4.3 mg/dl 2.6-4.7 Serum


Method:PHOSPHOMOLYBDATE

SODIUM 142 mmol/L 135-148 Serum


Method:Direct ISE

POTASSIUM 4.4 mmol/L 3.5-5.1 Serum


Method:Direct ISE

CHLORIDE 104 mmol/L 98-107 Serum


Method:Direct ISE

THYROID PROFILE, TOTAL


T3, TOTAL 1.20 ng/ml 0.60-1.81 Serum
Method:CLIA

T4, TOTAL 8.6 µg/dL Infants (01-23 months) 6.0-13.2 Serum


Method:CLIA Children (02-12 years) 5.5-12.1
Adolescents (13-20 years) 5.5-
11.1Adults : 4.5-10.9Reference
Range Pregnant Euthyroid
Total T4 µg/dl: 6.4-10.7 µg/dl
THYROID STIMULATING 3.40 µlU/mL 0.48-4.17 Serum
HORMONE (TSH)
Method:CLIA

PEDIATRIC REFERENCE INTERVAL


Age group T3 (ng/ml) T4 (µg/dl) TSH (µIU/ml)
Infants (01-23 months) 1.17-2.39 6.0-13.2 0.87-6.15
Children (02-12 years) 1.05-2.07 5.5-12.1 0.67-4.16
Adolescents (13-20 years) 0.86-1.92 5.5-11.1 0.48-4.17

As per American Thyroid Association (ATA), treatment goal of TSH levels in pregnancy
Trimester TSH
Pregnancy 1st trimester: 0.10-2.50 µIU/ml

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 1 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:53 AM
Collected At : - Report : 09-Jun-2024 / 14:03 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Pregnancy 2nd trimester: 0.20-3.00 µIU/ml


Pregnancy 3rd trimester: 0.30-3.00 µIU/ml

Reference Range Pregnant Euthyroid Total T4 ug/dl: 6.4-10.7 µg/dl

Comments:
Thyroid function tests are a series of blood tests used to measure how well your thyroid gland is functioning. The thyroid produces 2 major
hormones Triiodothyronine T3 and Thyroxine T4.
Thyroid stimulating hormone TSH ±is a part of thyroid function test. It is a hormone secreted by pituitary gland in response to thyroid hormone
levels. It is secreted in larger amount if thyroid hormone levels are low and vice versa. TSH also exhibits circadian variations. Low levels are
found during daytime and peaks are found during just after midnight. The best way to avoid false fluctuations in lab test results is to have your
thyroid levels checked under same conditions.
Pregnancy has profound impact on thyroid gland and thyroid function.The gland increases 10-40% in size, along with approximately 50%
increase in T3/T4 production and 50% increase in iodine requirements. In most normal Pregnancies,TSH levels are Lower than pre-pregnancy
levels.This is more profound in twin pregnancies.Hypothyroidism ±Thyroid hormone deficiency
Symptoms ±weight gain, lack of energy, depression, brittle hair & nails
Causes ±Hashimoto's thyroiditis, congenital hypothyroidism, Iodine deficiency etc
Hyperthyroidism ±Thyroid hormone excess
Symptoms ±weight loss, anxiety, tremors, diarrhoea
Causes ±Grave¶s disease, Toxic adenoma, Toxic Multinodular goitre, Thyroiditis etc
Medications like steroids, aspirin, lithium, amiodarone and radio-iodine dye used in radiological procedures can interfere with Thyroid Function
Test results.

Verified By: 221344


Dr. Doddappa M B
PhD (Medical Biochemistry)
Consultant
--- End Of Report ---
Important Instructions:
‡Test results released pertain to specimen submitted.
‡All results are dependent upon the quality of specimen received in the laboratory.
‡Lab investigation is only a tool to faciilitate in concluding a diagnosis , and should be clinically correlated by the referring physician.
‡Certain tests may require further testing, at an additional cost for derivation of excact value. kindly submit request with in 2 days, post reporting.
‡Sample repeats are accepted on request of Referring Physician with in sample stability period.
‡Test results may show inter-laboratory variation.
‡Results are for informational purposes , and not intended to replace the care of medical practitionar, and does not recommend self-diagnosis
and/or self-medication.
‡Aster clinical Lab LLP does not make any warranties expressed or implied with respect to information herein.
‡Test results are not valid for medico legal purposes.
‡The courts/forum at Cochin/Bangolore shall have exclusive Jurisdiction in all disputes/claims concerning the request and/or result of test(s).
‡Contact customer care 9680396803 for all queries related to test results
Patient/Client is advised to contact the laboratory immediately, for any possible remedial action, If test result is alarming or unexpected

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 2 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:43 AM
Collected At : - Report : 09-Jun-2024 / 11:49 AM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Haematology
Investigation Observed Value Unit Biological Ref. Interval Specimen

COMPLETE BLOOD COUNT


RBC Parameters
Haemoglobin 13.5 g/dL 13.0-17.0 K2EDTA
Method:Photometry WB

RBC Count 3.83 mil/cmm 4.5-5.5 K2EDTA


Method:Electrical Impedance/Flowcytometry WB

PCV 41.1 % 40-51 K2EDTA


Method:Calculated WB

MCV 107.5 fl 80-99 K2EDTA


Method:Calculated WB

MCH 33.3 pg 27.0-33.5 K2EDTA


Method:Calculated WB

MCHC 32.8 g/dL 31.5-36.0 K2EDTA


Method:Calculated WB
RDW-CV 15.4 % 11.6-14.0 K2EDTA
Method:Calculated WB
WBC Parameters
Total WBC Count 8860 /cmm 4000-11000 K2EDTA
Method:Electrical Impedance/Flowcytometry WB
WBC Differential
Neutrophils 51.4 % 40-80 K2EDTA
Method:Calculated WB
Lymphocytes 37.5 % 20-45 K2EDTA
Method:Calculated WB
Monocytes 7.6 % 2-10 K2EDTA
Method:Calculated WB
Eosinophils 2.7 % 1-6 K2EDTA
Method:Calculated WB
Basophils 0.8 % 0-2 K2EDTA
Method:Calculated WB
Absolute Counts
Absolute Neutrophils 4550 /cmm 1700-8800 K2EDTA
Method:Measured WB
Absolute Lymphocytes 3322 /cmm 1100-4500 K2EDTA
Method:Measured WB
Absolute Monocytes 670 /cmm 100-1000 K2EDTA
Method:Measured WB

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 3 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:43 AM
Collected At : - Report : 09-Jun-2024 / 11:49 AM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Absolute Eosinophils 240 /cmm 20-500 K2EDTA


Method:Measured WB
Absolute Basophils 70 /cmm 0-200 K2EDTA
Method:Measured WB
Platelet Parameters
Platelet Count 340000 /cmm 150000-400000 K2EDTA
Method:Electrical Impedance/Flowcytometry WB
MPV 7.9 fl 6-11 K2EDTA
Method:Calculated WB

Comments:

‡ A complete blood count (CBC) is a blood test which measures several cellular components of blood and is used to evaluate overall
health and detect a wide range of disorders.
‡ It is used to determine one¶s general health status; to screen for, diagnose, or monitor a variety of diseases and conditions that affect
blood cells, such as anemia, infection, inflammation, bleeding disorder or cancer.
‡ A decrease in hemoglobin levels/ RBC count lower than the normal reference range for the given age can signify anemia. Further
investigation with iron studies, vitamin B12 and folic acid levels will help in determining the cause and assist in further treatment. Red
cell indices help in classification of anaemia and give a clue to their etiology. An increase in haemoglobin level may signify
polycythemia, dehydration and is often seen in smokers.
‡ White blood cell (WBC) counts and their differential counts (DC) are used to diagnose infections(bacterial/viral), allergies, inflammatory
conditions and leukemias.
‡ Platelets help in clotting of blood, any substantial decrease may increase the risk of bleeding

Note
The differential leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of blood as per the
recommendation of International council for Standardization in Hematology.

Verified By: 223952


Dr. HEMA N ANADURE
M.D (Pathology)
Consultant
--- End Of Report ---
Important Instructions:
‡Test results released pertain to specimen submitted.
‡All results are dependent upon the quality of specimen received in the laboratory.
‡Lab investigation is only a tool to faciilitate in concluding a diagnosis , and should be clinically correlated by the referring physician.
‡Certain tests may require further testing, at an additional cost for derivation of excact value. kindly submit request with in 2 days, post reporting.
‡Sample repeats are accepted on request of Referring Physician with in sample stability period.
‡Test results may show inter-laboratory variation.
‡Results are for informational purposes , and not intended to replace the care of medical practitionar, and does not recommend self-diagnosis
and/or self-medication.
‡Aster clinical Lab LLP does not make any warranties expressed or implied with respect to information herein.
‡Test results are not valid for medico legal purposes.
‡The courts/forum at Cochin/Bangolore shall have exclusive Jurisdiction in all disputes/claims concerning the request and/or result of test(s).
‡Contact customer care 9680396803 for all queries related to test results
Patient/Client is advised to contact the laboratory immediately, for any possible remedial action, If test result is alarming or unexpected

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 4 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:51 AM
Collected At : - Report : 09-Jun-2024 / 14:03 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Biochemistry
Investigation Observed Value Unit Biological Ref. Interval Specimen

GLUCOSE, FASTING (F) 92.0 mg/dl Non-Diabetic: < 100 Fluoride


Method:Hexokinase Prediabetes :100-125 Plasma (F)
Diabetic: >/= 126

Comments:
Glucose is a simple sugar(monosaccharide) obtained by breakdown of carbohydrates. It is the main source of energy in the body. This test
measures glucose levels in the blood after 8-12 hrs of fasting.

Clinical uses:
1. Diagnosis and monitoring of Diabetes(hyperglycemia)
2. Diagnosis and monitoring of Hypoglycemia
3. Diagnosis of some endocrinal disorders

High levels are seen in:


1. Diabetes ±Type 1 and 2
2. Gestational Diabetes
3. Stress, surgery
4. Endocrinal disorders ±Hyperthyroidism, Hypercortisolism
5. Pancreatic disorders ±Pancreatitis, Glucagonoma
6. Drugs such as steroids, Hydrocortisone

Low levels are seen in:


1. Insulinoma
2. Overdose of Anti diabetic drugs & Insulin
3. Starvation
4. Endocrinal disorders ±Hypothyroidism, Hypopituitarism, Addison¶s disease
5. Chronic kidney and liver disorders

Verified By: 221344


Dr. Doddappa M B
PhD (Medical Biochemistry)
Consultant
--- End Of Report ---
Important Instructions:
‡Test results released pertain to specimen submitted.
‡All results are dependent upon the quality of specimen received in the laboratory.
‡Lab investigation is only a tool to faciilitate in concluding a diagnosis , and should be clinically correlated by the referring physician.
‡Certain tests may require further testing, at an additional cost for derivation of excact value. kindly submit request with in 2 days, post reporting.
‡Sample repeats are accepted on request of Referring Physician with in sample stability period.
‡Test results may show inter-laboratory variation.
‡Results are for informational purposes , and not intended to replace the care of medical practitionar, and does not recommend self-diagnosis
and/or self-medication.
‡Aster clinical Lab LLP does not make any warranties expressed or implied with respect to information herein.
‡Test results are not valid for medico legal purposes.
‡The courts/forum at Cochin/Bangolore shall have exclusive Jurisdiction in all disputes/claims concerning the request and/or result of test(s).
‡Contact customer care 9680396803 for all queries related to test results
Patient/Client is advised to contact the laboratory immediately, for any possible remedial action, If test result is alarming or unexpected

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 5 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 13:58 PM
Collected At : - Report : 09-Jun-2024 / 14:43 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Biochemistry
Investigation Observed Value Unit Biological Ref. Interval Specimen

GLYCOSYLATED HEMOGLOBIN (HbA1c)


HbA1c 5.2 % Normal/Non-Diabetic Level: 4 - 5.6 EDTA WB
Method:HPLC Prediabetic Level: 5.7-6.4
Diabetic Level: >6.5 Well
Controlled Diabetes: <7.0
Unsatisfactory Control : 7.1 - 8
Poor Control : >8.0
ESTIMATED AVERAGE 102.54 mg/dl EDTA WB
GLUCOSE
Method:Calculated from HbA1c

Comments:
In persons with diabetes, optimal HbA1c value is as advised by your doctor.
Glucose combines with Hb continuously and nearly irreversibly during the lifespan of RBCs (120 days). Therefore, Glycosylated Haemoglobin
will be proportional to mean plasma Glucose during previous 6-12 weeks. Mean blood Glucose in first 30days (day 0-30) before sampling GHb
contributes approximately 50% to final GHb value, whereas days 90-120 contribute only approximately 10%. Time to reach a new steady state
is approximately 30-35 days.
A long-term diabetic who has recent good control may still show higher HbA1c% and a normal (or diabetic with previous good control) individual
with recent poor control can show normal (or lower than expected) HbA1c levels.
HbA1c in pregnancy has limited role in diagnosing gestational diabetes. Physiological changes lower HbA1c levels, and pregnancy-specific
reference ranges may need to be recognized. In these cases, a fasting plasma glucose, oral glucose tolerance test or fructosamine test should
be used for screening or diagnosing diabetes.

Verified By: 221344


Dr. Doddappa M B
PhD (Medical Biochemistry)
Consultant
--- End Of Report ---
Important Instructions:
‡Test results released pertain to specimen submitted.
‡All results are dependent upon the quality of specimen received in the laboratory.
‡Lab investigation is only a tool to faciilitate in concluding a diagnosis , and should be clinically correlated by the referring physician.
‡Certain tests may require further testing, at an additional cost for derivation of excact value. kindly submit request with in 2 days, post reporting.
‡Sample repeats are accepted on request of Referring Physician with in sample stability period.
‡Test results may show inter-laboratory variation.
‡Results are for informational purposes , and not intended to replace the care of medical practitionar, and does not recommend self-diagnosis
and/or self-medication.
‡Aster clinical Lab LLP does not make any warranties expressed or implied with respect to information herein.
‡Test results are not valid for medico legal purposes.
‡The courts/forum at Cochin/Bangolore shall have exclusive Jurisdiction in all disputes/claims concerning the request and/or result of test(s).
‡Contact customer care 9680396803 for all queries related to test results
Patient/Client is advised to contact the laboratory immediately, for any possible remedial action, If test result is alarming or unexpected

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 6 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 13:02 PM
Collected At : - Report : 09-Jun-2024 / 17:04 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Clinical Pathology
Investigation Result Unit Biological Ref. Interval Specimen

URINE ROUTINE EXAMINATION


PHYSICAL EXAMINATION
Color Pale yellow Pale Yellow Spot urine
Method:Manual

pH-Urine 6.0 4.5 - 8.0 Spot urine


Method:Methyl red sodium salt-bromthymol blue

Specific Gravity Urine 1.025 1.003-1.030 Spot urine


Method:Bromthymol blue indicator

Transparency Clear Clear Spot urine


Method:Manual

Volume (ml) 30 ml Spot urine


Method:Manual

CHEMICAL EXAMINATION
Proteins Negative Negative Spot urine
Method:Tetrabromophenol blue

Glucose Negative Negative Spot urine


Method:Oxidase-peroxidase

Ketones Negative Negative Spot urine


Method:Sodium nitroprusside

Blood Negative Negative Spot urine


Method:Tetramethylbenzidine

Bilirubin Negative - Negative Spot urine


Method:Diazonium Salt

Urobilinogen Normal Normal Spot urine


Method:Diazonium Salt

Nitrite Negative Negative Spot urine


Method:P-arsanilic acid

MICROSCOPIC EXAMINATION
Pus cells 02 /hpf 0-5 Spot urine
Method:Microscopy

RBC Absent /hpf 0-2 Spot urine


Method:Microscopy

Epithelial Cells 02 /hpf 0-5 Spot urine


Method:Microscopy

Casts Absent Absent Spot urine


Method:Microscopy

Crystals Absent Absent Spot urine


Method:Microscopy

Amorphous debris Absent Absent Spot urine


Method:Microscopy

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 7 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 13:02 PM
Collected At : - Report : 09-Jun-2024 / 17:04 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Bacteria Absent Absent Spot urine


Method:Microscopy

Interpretation

‡ A urinalysis is a group of physical, chemical, and microscopic tests done on a fresh urine sample. The tests
detect and/or measure several substances in the urine, such as glucose, nitrites, bilirubin proteins, albumin,
cells like RBC, WBC, casts, and bacteria.
‡ Many disorders may be detected in their early stages by identifying substances that are not normally present
in the urine and/or by measuring abnormal levels of certain substances.
‡ As urine is produced by the kidneys, urine testing is useful in diagnosis and monitoring of diseases of kidney,
urinary tract and bladder.
‡ Presence of significant amount of glucose in urine is an indication of diabetes.
‡ Presence of RBC casts, WBC casts or granular casts is indication of diseases of the Kidney.
‡ Presence of bacteria in urine should be correlated with clinical symptoms of urinary tract infection and urine
culture reports.

Verified By: 223952


Dr. HEMA N ANADURE
M.D (Pathology)
Consultant
--- End Of Report ---
Important Instructions:
‡Test results released pertain to specimen submitted.
‡All results are dependent upon the quality of specimen received in the laboratory.
‡Lab investigation is only a tool to faciilitate in concluding a diagnosis , and should be clinically correlated by the referring physician.
‡Certain tests may require further testing, at an additional cost for derivation of excact value. kindly submit request with in 2 days, post reporting.
‡Sample repeats are accepted on request of Referring Physician with in sample stability period.
‡Test results may show inter-laboratory variation.
‡Results are for informational purposes , and not intended to replace the care of medical practitionar, and does not recommend self-diagnosis
and/or self-medication.
‡Aster clinical Lab LLP does not make any warranties expressed or implied with respect to information herein.
‡Test results are not valid for medico legal purposes.
‡The courts/forum at Cochin/Bangolore shall have exclusive Jurisdiction in all disputes/claims concerning the request and/or result of test(s).
‡Contact customer care 9680396803 for all queries related to test results
Patient/Client is advised to contact the laboratory immediately, for any possible remedial action, If test result is alarming or unexpected

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 8 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:53 AM
Collected At : - Report : 09-Jun-2024 / 14:03 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Biochemistry
Investigation Observed Value Unit Biological Ref. Interval Specimen

LIPID PROFILE
TOTAL CHOLESTEROL 168.0 mg/dl Optimal : < 200Border Line : 200 - Serum
Method:CHOD-POD 239High : >= 240

TRIGLYCERIDES 147.0 mg/dl Optimal : <150 Serum


Method:GOD-POD Borderline-high: 150 - 199
High: 200 - 499
Very high: >500

HDL CHOLESTEROL 28.0 mg/dl Desirable: >60 Serum


Method:Elimination/Catalase Borderline: 40 - 60
Low (High risk): <40
Non HDL CHOLESTEROL 140 mg/dl Optimal : <130Above Optimal : Serum
Method:Calculated 130 - 159Border Line High : 160 -
189High : 190 - 219Very High :
>=220
LDL CHOLESTEROL 114.0 mg/dl Optimal: <100 Serum
Method:Elimination/Catalase Above Optimal: 100 - 129
Borderline High: 130 - 159
High: 160 - 189
Very High: >190
VLDL 29.4 mg/dl 2.0-31.2 Serum
Method:Calculated

TOTAL CHOLESTEROL/HDLC 6.0 0-4.5 Serum


RATIO
Method:Calculated

LDLC/HDLC RATIO 4.07 0-3.5 Serum


Method:Calculated

Comments:
Lipid profile is a panel of blood tests that serves as an initial screening tool for abnormalities in lipids, such as cholesterol and triglycerides. The
lipid panel is used as part of a cardiac risk assessment to help determine your risk of heart disease and to help make decisions about what
treatment may be best if you have borderline, intermediate or high risk.

The results of the lipid panel are considered along with other known risk factors of heart disease to develop a plan of treatment and follow up.
Depending on the results and other risk factors, treatment options may involve lifestyle changes such as diet and exercise or medications that
lower lipid levels, typically statins.

Additionally a lipid panel may be used to monitor whether treatment has been effective in lowering cholesterol levels.

NLA 2014-15 guidelines:


1. Non±HDL-C (calculated as total C ±HDLC) represents the sum of cholesterol carried by all potentially atherogenic, apo B-containing
lipoprotein particles, including LDL, IDL, Lp (a), VLDL (including VLDL remnants), and chylomicron particles and remnants.
2. An elevated level of cholesterol carried by circulating apolipoprotein (apo) B±containing lipoproteins (non±HDL-C and LDL-C, termed
atherogenic cholesterol) is a root cause of atherosclerosis/ASCVD. HDL-C is responsible for lowering peripheral tissue cholesterol(reverse
transport), inturn reducing risk of ASCVD.
3. Apolipoprotein B, hsCRP, Lp(a) and LP-PLA2 testing should be considered in patients with moderate risk for ASCVD.
4. In all adults (>20 years of age), a fasting or nonfasting lipid profile should be obtained at least every 5 years. At a minimum, this should
include total cholesterol and HDL-C, which allows calculation of non-HDL-C (total-C ±HDL-C). If fasting (generally 9±12 hours), the LDL-C level
Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 9 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:53 AM
Collected At : - Report : 09-Jun-2024 / 14:03 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

may be calculated, provided that the triglyceride concentration is <400 mg/dL.


5. Apo B is considered an optional, secondary target for treatment. Epidemiologic studies have generally shown that both apo B and non±HDL-C
are better predictors of ASCVD risk than LDL-C. Apo B and non±HDL-C share the advantage that neither requires fasting sample for accurate
assessment.
6. Elevated triglyceride level is not a target of therapy per se, except when very high (>500 mg/dL). When triglycerides are between 200 and
499 mg/dL, the targets of therapy are non±HDL-C and LDL-C. When triglycerides are very high (>500 mg/dL, and especially if >1000 mg/dL),
reduction to <500 mg/dL to prevent pancreatitis becomes the primary goal of therapy.
7. Lifestyle therapies for ASCVD risk reduction generally include interventions aimed at (1) dietary modifications (2) reducing total energy intake
to lower body weight and adiposity for those who are overweight or obese; (3) exercise (4) improving risk factors associated with the metabolic
syndrome (adiposity, dyslipidemia, high blood pressure, and elevated plasma glucose); and (5) ceasing tobacco use.

Verified By: 221344


Dr. Doddappa M B
PhD (Medical Biochemistry)
Consultant
--- End Of Report ---
Important Instructions:
‡Test results released pertain to specimen submitted.
‡All results are dependent upon the quality of specimen received in the laboratory.
‡Lab investigation is only a tool to faciilitate in concluding a diagnosis , and should be clinically correlated by the referring physician.
‡Certain tests may require further testing, at an additional cost for derivation of excact value. kindly submit request with in 2 days, post reporting.
‡Sample repeats are accepted on request of Referring Physician with in sample stability period.
‡Test results may show inter-laboratory variation.
‡Results are for informational purposes , and not intended to replace the care of medical practitionar, and does not recommend self-diagnosis
and/or self-medication.
‡Aster clinical Lab LLP does not make any warranties expressed or implied with respect to information herein.
‡Test results are not valid for medico legal purposes.
‡The courts/forum at Cochin/Bangolore shall have exclusive Jurisdiction in all disputes/claims concerning the request and/or result of test(s).
‡Contact customer care 9680396803 for all queries related to test results
Patient/Client is advised to contact the laboratory immediately, for any possible remedial action, If test result is alarming or unexpected

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 10 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:53 AM
Collected At : - Report : 09-Jun-2024 / 14:03 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

Biochemistry
Investigation Observed Value Unit Biological Ref. Interval Specimen

LIVER FUNCTION TEST


BILIRUBIN TOTAL 0.68 mg/dl 0.3-1.2 Serum
Method:Vanadate Oxidation

BILIRUBIN DIRECT 0.27 mg/dl <0.3 Serum


Method:Vanadate Oxidation

BILIRUBIN INDIRECT 0.41 mg/dl 0.1-1.0 Serum


Method:Calculated

TOTAL PROTEIN 7.4 g/dL 6.4-8.6 Serum


Method:Biuret

ALBUMIN 4.5 g/dL 3.5-5.20 Serum


Method:Bromocresol Purple

GLOBULIN 2.9 g/dL 2.3-3.5 Serum


Method:Calculated

A/G RATIO 1.55 1-2 Serum


Method:Calculated

SGOT(AST) 16.0 U/L 15-37 Serum


Method:Modified IFCC

SGPT (ALT) 32.0 U/L 16-63 Serum


Method:Modified IFCC

GGT 29.0 U/L 15-85 Serum


Method:Modified IFCC

ALKALINE PHOSPHATASE 85.0 U/L 98-317 Serum


Method:IFCC

Total Bilirubin in Neonates


Age Premature (mg/dl) Mature (mg/dl)
0-1 day 1.0-8.0 2.0-6.0
1-2 days 6.0-12.0 6.0-10.0
3-5 days 10.0-14.0 4.0-8.0
*Teitz 5th ed

ALP in paediatric age group


Reference range IU/L
0-1 yr 150-350
1-16 yr 30-300
*Wallach 10th ed

Comments:
These are a panel of tests that help determine health of the liver by measuring the levels of proteins, liver enzymes and bilirubin in the blood. It
helps the clinician in differentiating between pre-hepatic, hepatic and post -hepatic causes of some conditions exhibiting jaundice as a symptom.
It is recommended in the following conditions:
1. To check for damage from liver infections (Hepatitis B, C etc)
2. To monitor the side effects of certain hepatotoxic drugs
3. To monitor effectiveness of treatment for liver diseases
4. If symptoms of liver or gall bladder conditions are seen (like jaundice, itchiness etc)

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 11 Of 12
TEST REPORT
Lab. Id : P2277957 Hosp. UHID : Reg. Date : 09-Jun-2024 / 08:33 AM
Name : MR. KUSHAL S Collection : 09-Jun-2024 / 08:43 AM
Age/Gender : 18Y-5M-25D / Male Received : 09-Jun-2024 / 10:53 AM
Collected At : - Report : 09-Jun-2024 / 14:03 PM
Referral Dr : DR.ASHOK SHETTY Report Status : Preliminary Print :
Bed
:

5. For certain medical conditions like diabetes, high triglycerides, anaemia etc

Verified By: 221344


Dr. Doddappa M B
PhD (Medical Biochemistry)
Consultant
--- End Of Report ---
Important Instructions:
‡Test results released pertain to specimen submitted.
‡All results are dependent upon the quality of specimen received in the laboratory.
‡Lab investigation is only a tool to faciilitate in concluding a diagnosis , and should be clinically correlated by the referring physician.
‡Certain tests may require further testing, at an additional cost for derivation of excact value. kindly submit request with in 2 days, post reporting.
‡Sample repeats are accepted on request of Referring Physician with in sample stability period.
‡Test results may show inter-laboratory variation.
‡Results are for informational purposes , and not intended to replace the care of medical practitionar, and does not recommend self-diagnosis
and/or self-medication.
‡Aster clinical Lab LLP does not make any warranties expressed or implied with respect to information herein.
‡Test results are not valid for medico legal purposes.
‡The courts/forum at Cochin/Bangolore shall have exclusive Jurisdiction in all disputes/claims concerning the request and/or result of test(s).
‡Contact customer care 9680396803 for all queries related to test results
Patient/Client is advised to contact the laboratory immediately, for any possible remedial action, If test result is alarming or unexpected

Aster Clinical Lab-Bengaluru Reference Lab,24 Venkatappa Road, Tasker Town, Vasanthnagar, Bangalore -
560051

Page 12 Of 12

You might also like